ConductScience.org, home

Gene · 114907

FBXO32: F-box protein 32

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. FBXO32: F-box protein 32. Genes, record 114907. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/114907

On this page

Gene

Symbol
FBXO32
HGNC
Name
F-box protein 32
HGNC
NCBI Gene ID
114907
NCBI Gene
HGNC ID
HGNC:16731
HGNC
Ensembl
ENSG00000156804
NCBI Gene
Aliases
ATROGIN1, Fbx32, MAFbx
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q969P5F-box only protein 323550Ensembl, GeneID, HGNC

Source UniProt

Patents36

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1446030Q969P5Espacenet
EP 4650780 A22025-11-1915102Q969P5Espacenet
EP 4641202 A22025-10-297399Q969P5Espacenet
JP 2025517970 A2025-06-1215102Q969P5Espacenet
JP 2025032204 A2025-03-1128306Q969P5Espacenet
KR 1020250017231 A2025-02-047399Q969P5Espacenet
EP 4461818 A22024-11-1328306Q969P5Espacenet
EP 4366774 A22024-05-15503Q969P5Espacenet
JP 2023058610 A2023-04-2528306Q969P5Espacenet
US 11446398 B22022-09-2031173Q969P5Espacenet

1 to 10 of 36

See all 36 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,270

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFBXO32 papersNewest fiscal year
P30AG024832UTMB Claude D. Pepper Older Americans Independence Center112025
P30AG028740University of Florida Older Americans Independence Center (OAIC)112025
R01DK037175Protein Nutrition in Experimental Uremia82025
P60AA009803LSUHSC-NO Comprehensive Alcohol-HIV/AIDS Research Center (CARC)62025
R01HL070241Insulin-Like Growth Factor-1 and Atherosclerosis62025
P20GM103427Nebraska Research Network in Functional Genomics42025
P30AG021332Wake Forest Claude D. Pepper OAIC - Renewal42025
P30AG031679Boston OAIC: A Translational Approach to Function Promoting Therapies42025
P30CA068485Cancer Center Support Grant42025
P30DK048520Colorado Nutrition Obesity Research Center42025

1 to 10 of 1,270Source NIH's project files

See all 1,270 nih grants

Papers2,920

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Pathophysiology of sarcopenia in chronic pancreatitis: Insights from muscle biopsy and molecular profiling.Pancreatology202642816254PubTator, text miningPubMed
FBXO11 and FBXO32 are associated with TRAF3-TBK1-IRF3 signaling components in chronic hepatitis B: evidence from clinical samples and preliminary mechanistic studies.Am J Transl Res202642769254PubTator, text miningPubMed
FBXO11 and FBXO32 synergistically activate innate immunity against hepatitis B virus in a NEDD8-dependent manner.Front Immunol202642756518PubTator, text miningPubMed
Identification of Isoliensinine as a Novel CCR5 Inhibitor for the Prevention of Skeletal Muscle Atrophy Through Virtual Screening and Experimental Validation.Molecules202642653918PubTator, text miningPubMed
Stage-dependent doxorubicin toxicity impairs C2C12 myogenesis via AMPK/AKT-FOXO signaling and is attenuated by metformin.Environ Toxicol Pharmacol202642648387PubTator, text miningPubMed
Hysterectomy accelerates sarcopenia risk in US women and mouse models.Front Endocrinol (Lausanne)202642523681PubTator, text miningPubMed
Naphthalene-Type Glycosides from Rumex obtusifolius Roots and Their Protective Effects Against Muscle Atrophy in C2C12 Myotubes.Pharmaceutics202642514887PubTator, text miningPubMed
β-Hydroxy-β-methylbutyrate (HMB) Counteracts Atrophy and Restores Circadian Rhythms in Myotubes.Int J Mol Sci202642511533PubTator, text miningPubMed
CXCL2 is a modifiable driver of sarcopenic inflammation attenuated by exercise in older women: Integrated transcriptomic and experimental evidence.J Sport Health Sci202642486363PubTator, text miningPubMed
Selective Small-Molecule AdipoR1 Agonist 3-Hydroxy Pterocarpan Salt (CDRI-1709S) Ameliorates Skeletal Muscle Atrophy.J Cachexia Sarcopenia Muscle202642480512PubTator, text miningPubMed

1 to 10 of 2,920

See all 2,920 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/114907

GET https://conductscience.org/api/genes/v1/114907/patents?page=2